Blood protein clues may predict breast cancer return
NCT ID NCT04438681
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study looks at whether a simple blood test measuring certain proteins can help predict if triple-negative breast cancer will return after treatment. Researchers will follow 90 women with early-stage triple-negative breast cancer, collecting blood samples at key points during their care. The goal is to find patterns that signal a higher risk of the cancer spreading, which could lead to better monitoring and earlier treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Jean PERRIN
Clermont-Ferrand, 63011, France
Conditions
Explore the condition pages connected to this study.